2003
DOI: 10.1016/s0195-6701(03)00088-4
|View full text |Cite
|
Sign up to set email alerts
|

Proton pump inhibitors as a risk factor for Clostridium difficile diarrhoea

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

2
161
3
6

Year Published

2005
2005
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 299 publications
(173 citation statements)
references
References 11 publications
2
161
3
6
Order By: Relevance
“…Older age, female gender and a prolonged hospital stay were identified risk factors in hospitalized CDAD patients (Al-Eidan et al, 2000). More recent studies reported the association of the use of proton pump inhibitors within the preceding 8 weeks, the use of nasal feeding tubes and exposure to antineoplastic agents with an increased risk of C. difficile diarrhoea (Cunningham et al, 2003;Komatsu et al, 2003). Some of the risk factors identified in this study differ from those reported in other investigations.…”
Section: Discussioncontrasting
confidence: 63%
“…Older age, female gender and a prolonged hospital stay were identified risk factors in hospitalized CDAD patients (Al-Eidan et al, 2000). More recent studies reported the association of the use of proton pump inhibitors within the preceding 8 weeks, the use of nasal feeding tubes and exposure to antineoplastic agents with an increased risk of C. difficile diarrhoea (Cunningham et al, 2003;Komatsu et al, 2003). Some of the risk factors identified in this study differ from those reported in other investigations.…”
Section: Discussioncontrasting
confidence: 63%
“…10 Changes to existing PPI prescribing practices might be warranted if exposure increases the risk or severity of CDI by a clinically relevant magnitude. A relationship between PPI use and CDI risk has been both supported [11][12][13][14][15][16][17][18][19][20] and refuted 6,[21][22][23] by recent epidemiological studies. Several of these studies were conducted during hospital outbreaks of the NAP1 strain.…”
Section: Introductionmentioning
confidence: 99%
“…Several of these studies were conducted during hospital outbreaks of the NAP1 strain. 6,12,13,17,22,23 Two studies have examined the association of PPI to CDI in an endemic hospital setting; 16,19 others did not describe the epidemiology of CDI in the hospital 11,18 or were community-based studies. 14,15,21 The rate of new CDI cases in Calgary, Alberta, Canada at three acute adult hospitals is low compared to that in Quebec, ranging from 1.0 to 2.9 cases ⁄ 1000 admissions during the period from 2003 to 2007.…”
Section: Introductionmentioning
confidence: 99%
“…This practice is unjustified, and there is no evidence-based data that support the continuation of AST at discharge [57,58] . Furthermore, long-term use of acid-suppression medications was associated with an increase in unnecessary expenses [47,57] , and most importantly with an increased risk of pneumonia [59] , hip fracture [60] and Clostridium difficile colitis [61,62] . In order to explore whether teaching hospitals are more compliant with SUP guidelines, patients were stratified into two groups, resulting in statistically significant differences: a higher proportion of inpatients in teaching healthcare centers received adequate prophylaxis compared to patients in non-teaching hospitals.…”
mentioning
confidence: 99%